Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?

Fernandez-Fernandez B, Fernandez-Prado R, Górriz JL, Martinez-Castelao A, Navarro-González JF, Porrini E, Soler MJ, Ortiz A.

Clin Kidney J. 2019 May 31;12(3):313-321. doi: 10.1093/ckj/sfz070. eCollection 2019 Jun.

2.

Positive/retained SDHB immunostaining in renal cell carcinomas associated to germline SDHB-deficiency: case report.

Ugarte-Camara M, Fernandez-Prado R, Lorda I, Rossello G, Gonzalez-Enguita C, Cannata-Ortiz P, Ortiz A.

Diagn Pathol. 2019 May 15;14(1):42. doi: 10.1186/s13000-019-0812-6.

3.

Clarifying the concept of chronic kidney disease for non-nephrologists.

Perez-Gomez MV, Bartsch LA, Castillo-Rodriguez E, Fernandez-Prado R, Fernandez-Fernandez B, Martin-Cleary C, Gracia-Iguacel C, Ortiz A.

Clin Kidney J. 2019 Feb 14;12(2):258-261. doi: 10.1093/ckj/sfz007. eCollection 2019 Apr.

4.

Potential Dangers of Serum Urate-Lowering Therapy.

Perez-Gomez MV, Bartsch LA, Castillo-Rodriguez E, Fernandez-Prado R, Kanbay M, Ortiz A.

Am J Med. 2019 Apr;132(4):457-467. doi: 10.1016/j.amjmed.2018.12.010. Epub 2019 Jan 3. Review.

PMID:
30611833
5.

Incidence of Hypersensitivity Reactions During Hemodialysis.

Esteras R, Martín-Navarro J, Ledesma G, Fernández-Prado R, Carreño G, Cintra M, Cidraque I, Sanz I, Tarragón B, Alexandru S, Milla M, Astudillo E, Sánchez E, Mas S, Tejeiro RD, Ortiz A, Sánchez R, González-Parra E.

Kidney Blood Press Res. 2018;43(5):1472-1478. doi: 10.1159/000493662. Epub 2018 Sep 20.

6.

Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression.

Castillo-Rodriguez E, Fernandez-Prado R, Esteras R, Perez-Gomez MV, Gracia-Iguacel C, Fernandez-Fernandez B, Kanbay M, Tejedor A, Lazaro A, Ruiz-Ortega M, Gonzalez-Parra E, Sanz AB, Ortiz A, Sanchez-Niño MD.

Toxins (Basel). 2018 Jul 19;10(7). pii: E300. doi: 10.3390/toxins10070300. Review.

7.

Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.

Castillo-Rodriguez E, Fernandez-Prado R, Ortiz A.

N Engl J Med. 2018 Jun 28;378(26):2539. doi: 10.1056/NEJMc1805679. No abstract available.

PMID:
29952173
8.

Women and renal replacement therapy in Europe: lower incidence, equal access to transplantation, longer survival than men.

Fernandez-Prado R, Fernandez-Fernandez B, Ortiz A.

Clin Kidney J. 2018 Feb;11(1):1-6. doi: 10.1093/ckj/sfx154. Epub 2018 Feb 6.

9.

Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease.

Fernandez-Prado R, Esteras R, Perez-Gomez MV, Gracia-Iguacel C, Gonzalez-Parra E, Sanz AB, Ortiz A, Sanchez-Niño MD.

Nutrients. 2017 May 12;9(5). pii: E489. doi: 10.3390/nu9050489. Review.

10.

Kidney Injury Marker 1 and Neutrophil Gelatinase-Associated Lipocalin in Chronic Kidney Disease.

Castillo-Rodriguez E, Fernandez-Prado R, Martin-Cleary C, Pizarro-Sánchez MS, Sanchez-Niño MD, Sanz AB, Fernandez-Fernandez B, Ortiz A.

Nephron. 2017;136(4):263-267. doi: 10.1159/000447649. Epub 2016 Oct 22. Review.

11.

Creatinine Clearance Is Not Equal to Glomerular Filtration Rate and Cockcroft-Gault Equation Is Not Equal to CKD-EPI Collaboration Equation.

Fernandez-Prado R, Castillo-Rodriguez E, Velez-Arribas FJ, Gracia-Iguacel C, Ortiz A.

Am J Med. 2016 Dec;129(12):1259-1263. doi: 10.1016/j.amjmed.2016.08.019. Epub 2016 Sep 6. Review.

PMID:
27612441

Supplemental Content

Loading ...
Support Center